Sunday, October 11, 2026

Aphria Stock Is 3% Down So Far Today

ViaNews Editorial Team

December 17, 2020

Aphria Stock Is 3% Down So Far Today

Shares of Aphria dropped 3.6% to $7.76 at 11:52 EST on Thursday, following yesterday's downward trend. The Nasdaq Stock Market is jumping 0.54% to $12,727.00, after three consecutive sessions in a row of gains. This seems, as yet, a somewhat positive trend trading session today.

Aphria's last close was $8.05, 14.43% under its 52-week high of $8.88.

Aphria's Stock Yearly Top and Bottom Value

Aphria's stock is valued at $7.76 at 11:52 EST, way below its 52-week high of $8.88 and way above its 52-week low of $1.95.

Aphria's Moving Average

Aphria's worth is way above its 50-day moving average of $6.62 and way higher than its 200-day moving average of $5.18.

Previous days news about Aphria

Aphria, tilray announce deal to create biggest cannabis company. According to Bloomberg Quint on Wed Dec 16, "A new giant in the fast-growing cannabis industry will be created after Tilray Inc. and Aphria Inc. agreed to combine their operations.", "Through Tuesday's close, Tilray shares have fallen 54% in 2020, while Aphria's have risen 56%."

Tilray stock soars after 'reverse' merger deal with Aphria at a 23% premium. According to MarketWatch on Wed Dec 16, "Shares of Tilray Inc. soared 30.8% in premarket trading and Aphria Inc.'s U.S.-listed stock surged 9.9%, after the Canada-based cannabis companies announced a merger, which they say will create the largest global cannabis company, with a combined equity value of about $3.9 billion. ", "After the deal closes, which the companies said was structured has a "reverse acquisition" of Tilray, Aphria shareholders will own 62% of outstanding Tilray shares. "

Stocks making the biggest moves in the premarket: tilray, Aphria, penumbra, Moderna & more. According to CNBC on Wed Dec 16, "Tilray (TLRY), Aphria (APHA) - The Canadian cannabis companies will combine in an all-stock deal that will create the world's biggest cannabis producer. ", "Tilray shares surged 30%, while Aphria shares jumped more than 8% in the premarket."

Aphria and tilray to merge to create biggest global cannabis company. According to The Wall Street Journal on Wed Dec 16, "Aphria Inc. and Tilray Inc. said Wednesday their proposed combination would create a company with annual revenue on a pro-forma basis of Canadian $874 million, equivalent to $686 million. ", "The deal between Aphria and Tilray could signal more mergers and acquisitions ahead across the industry, according to some analysts. "

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Agentic AI Rewires Enterprise Software: Platform Incumbents, Governance, and a Funded Startup Wave
Enterprise software is being rebuilt around autonomous AI agents. Incumbents and large platforms (SAP with its Autonomous Suite and Joule, Zeta with AthenaOS/AIM/Athena MCP, Meta with its new Enterprise Platform) are racing to own the agent layer. Meanwhile, seed and Series A money flows to finance-office and vertical startups (Dextr, Latitude, Dentira, Light), and consolidation continues through acquisitions (Tiny–Oso Cloud, Harvey–Guardrails AI). Investor commentary stresses that AI is better at disrupting around the edges of systems of record than at replacing them, that it should not be trusted with finance calculations, and that governance must be enforced by the system rather than left to agents.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,369 source documents archived
Query this data → isubstrate.com